One Step Forward
The European Food Safety Authority (EFSA) has established the safety of Lipid Nutrition’s Clarinol® CLA (polyunsaturated, conjugated fatty acid) in the EU’s Novel Food registration process. This assessment is a step toward allowing the product to be used in food products throughout Europe, helping to build a long-term, sustainable market. The core conclusion of the EFSA Panel is the safety of Clarinol has been established for the proposed intake necessary to attain the results, as described by the weight management health claims, which are still under evaluation by EFSA as part of the article list of generic health claims. Lipid Nutrition, the Netherlands, + 31 75 629 2461, www.lipidnutrition.com
Stable and Effective Probiotic
Premium probiotic blends containing the superstrain, Lactobacillus acidophilus DDS®-1, from UAS Laboratories, have demonstrated condition-specific health benefits, says the company. A recent clinical case study demonstrated the effectiveness of the probiotic blend containing L. acidophilus DDS-1, Bifidobacterium longum, Bifidobacterium lactis and Bifidobacterium bifidum in treating irritable bowel syndrome (IBS). A clinical study published last year demonstrated effectiveness of the L. acidophilus DDS-1, B. lactis blend in reducing the symptoms of atopic dermatitis in young children. The health attributes of L. acidophilus DDS-1 have been well-documented and include human isolates that adapt well to the human body; acid and bile resistance that make it well-suited for intestinal survival; ability to promote digestive health; creates an unfavorable environment for pathogens; maintains natural immune defenses; and contributes to good balance of intestinal flora. UAS Laboratories Inc., 952-935-1707, www.uaslabs.com